7Baggers

MEI Pharma, Inc
(NASDAQ:MEIP) 

MEIP stock logo

MEI Pharma, Inc., a late-stage pharmaceutical company, focuses on the development of various therapies for the treatment of cancer. The company develops Zandelisib, an oral phosphatidylinositol 3-kinase delta inhibitor that is in Phase II clinical trial for the treatment of patients with relapsed/re...

Founded: 2000
Full Time Employees: 51
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends